1. Home
  2. APLE vs CPRX Comparison

APLE vs CPRX Comparison

Compare APLE & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Apple Hospitality REIT Inc.

APLE

Apple Hospitality REIT Inc.

HOLD

Current Price

$14.50

Market Cap

2.9B

Sector

Real Estate

ML Signal

HOLD

Logo Catalyst Pharmaceuticals Inc.

CPRX

Catalyst Pharmaceuticals Inc.

HOLD

Current Price

$31.24

Market Cap

3.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
APLE
CPRX
Founded
2007
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
3.4B
IPO Year
2007
2006

Fundamental Metrics

Financial Performance
Metric
APLE
CPRX
Price
$14.50
$31.24
Analyst Decision
Buy
Strong Buy
Analyst Count
8
1
Target Price
$13.00
$35.00
AVG Volume (30 Days)
2.8M
3.2M
Earning Date
05-04-2026
05-11-2026
Dividend Yield
7.12%
N/A
EPS Growth
N/A
28.24
EPS
0.12
0.50
Revenue
$1,238,622,000.00
$119,072,803.00
Revenue This Year
$2.31
$9.20
Revenue Next Year
$2.35
$10.51
P/E Ratio
$120.75
$62.57
Revenue Growth
18.98
16.39
52 Week Low
$10.85
$19.05
52 Week High
$14.54
$32.56

Technical Indicators

Market Signals
Indicator
APLE
CPRX
Relative Strength Index (RSI) 68.49 72.98
Support Level $11.50 $22.24
Resistance Level N/A $31.29
Average True Range (ATR) 0.31 0.31
MACD 0.02 -0.13
Stochastic Oscillator 94.49 95.59

Price Performance

Historical Comparison
APLE
CPRX

About APLE Apple Hospitality REIT Inc.

Apple Hospitality REIT Inc is a real estate investment trust that invests in income-producing real estate, majorly in the lodging sector, in the United States. It chiefly invests in upscale service hotels. All of the company's hotels operate under the Marriott or Hilton brands. Apple Hospitality has wholly-owned taxable REIT subsidiaries, which lease all of the company's hotels from wholly-owned qualified REIT subsidiaries. These hotels are managed under separate agreements with various hotel management companies that are unaffiliated with Apple Hospitality. The company derives its income from hotel revenue, its sole segment.

About CPRX Catalyst Pharmaceuticals Inc.

Catalyst Pharmaceuticals Inc is a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare and difficult to treat diseases. The Company sells three commercial stage drug products, FIRDAPSE (amifampridine), AGAMREE (vamorolone), and FYCOMPA (perampanel). The Company is currently seeking to further expand its product portfolio, with a focus on acquiring the rights to immediately and near-term accretive assets to treat rare (orphan) diseases across therapeutic areas, including clinical-stage opportunities with established proof of concept.

Share on Social Networks: